GENE ONLINE|News &
Opinion
Blog

Lung Cancer
R&D
Scanning Some of 2024’s Biggest Medical Breakthroughs
2024-12-31
Trials & Approvals Lung CancerFDA Approval
AstraZeneca & Daiichi Sankyo Voluntarily Withdraw EU Submission for Lung Cancer Drug
2024-12-26
ESMO 2024 highlights
Highlights from ESMO 2024: Key Oncology Advances from Major Pharmaceutical Companies
2024-09-19
R&D MerckKeytruda
Merck’s KEYTRUDA Fails in Early-Stage Lung and Skin Cancer Trials, Ends Two Phase 3 Studies
2024-08-30
Interviews Lung CancerNSCLC
Strengthening Genetic Screening Platform in APAC for Lung Cancer Precision Medicine: An Interview with Dr. Koichi Goto
2023-06-05
Trials & Approvals NSCLC
Mirati Wins FDA Accelerated Approval For Lung Cancer Mutation
2022-12-14
Trials & Approvals NSCLC
Jounce’s Antibody Misses Primary Endpoint In Phase 2 Lung Cancer Study
2022-08-31
Trials & Approvals Lung Cancer
Novartis’s Lung Cancer Drug Approved for Marketing in Europe
2022-06-23
Regulatory FDA
FDA Plans to Prohibit Menthol Cigarettes and Flavored Cigars to Decrease Youth Smokers
2022-04-29
Regulatory BeiGene
EMA Begins Review of BeiGene, Novartis’s PD-1 Antibody for Esophageal and Lung Cancer
2022-04-13
R&D Immunotherapy
Roche’s Phase III Trial of ES-SCLC Immunotherapy Fails to Extend Progression-Free Survival
2022-04-05
Special
EQRx, CStone’s Low-Cost anti-PD-L1 Inhibitor Flaunts Encouraging Data in Stage 3 NSCLC
2021-09-19
Trials & Approvals Lung Cancer
NHS to Roll Out Revolutionary Lung Cancer Drug Targeting the Once ‘Undruggable’ KRAS
2021-09-12
Novel Mutational Patterns Explain Evolution of Lung Cancer in Never-Smokers
2021-09-09
Trials & Approvals
J&J’s FDA-Approved Bispecific Antibody Registers Promising Phase 1 Results for a Different Indication
2021-08-20
1 2 3 4
LATEST
Neuro, Pain, and Cancer Top the List at JPM 2025 Healthcare Conference
2025-01-17
ZYN Nicotine Pouches Receive FDA Marketing Authorization
2025-01-17
Virginia’s Insurance Marketplace Extends Open Enrollment Deadline: A Detailed Report
2025-01-16
2025 Starts with a Jolt: Layoffs Hit the Life Sciences Industry Ahead of JPM
2025-01-16
Eli Lilly Steals the Spotlight at JPM 2025 with $2.5 Billion Power Move Acquisition
2025-01-16
Pre-JPM 2025: The Quiet Deals You May Have Missed Before the Big Show
2025-01-16
JPM 2025’s Billion Dollar Deal – GSK Bids Big in GI Cancer
2025-01-15
READ MORE
EVENT
2025-02-05
Precision Medicine World Conference 2025
Santa Clara, California
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-02
Asia Cell and Gene Therapy Innovation Summit 2025
Shanghai, China
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top